Expression of Cyclin-dependent Kinase Inhibitor p27/Kipl and AP-1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma
Open Access
- 1 September 2002
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 93 (9) , 1000-1006
- https://doi.org/10.1111/j.1349-7006.2002.tb02476.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Protein Expression of Cell Cycle Regulator, p27Kip1, Correlates with Histopathological Grade of Non‐Hodgkin's LymphomaJapanese Journal of Cancer Research, 1999
- High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancersProceedings of the National Academy of Sciences, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsNature Medicine, 1997
- Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiationThe EMBO Journal, 1997
- A new group of conserved coactivators that increase the specificity of AP-1 transcription factorsNature, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoDScience, 1995
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994